Skip to main content
    S

    Sight Sciences Inc (SGHT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $9.32
    -0.25 (-2.61%)

    Market Cap: $513.42M

    Last updated: Oct 30, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    55%(12/22)
    Avg Surprise
    -7.05%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.12
    Range$-0.15 - $-0.08
    6 analysts
    EPS Revisions
    3
    0
    7d
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.16+25.4%
    60d ago$-0.13+6.2%
    30d ago$-0.13+6.2%
    7d ago$-0.13+6.2%
    Current$-0.12
    Revenue Consensus
    $24M
    Range$23M - $24M
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.03
    Range$-0.18 - $0.18
    6 analysts
    Revenue Consensus
    $27M
    Range$26M - $27M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.03---
    Sep 26EST
    		-$-0.12---
    Jun 26
    Reported Aug 5
    		$-0.08$-0.15+46.67%Beat+65.2%
    Mar 26
    Reported May 6
    		$-0.24$-0.20-20.00%Miss+14.3%
    Dec 25
    Reported Mar 4
    		$-0.08$-0.15+47.68%Beat+65.2%
    Sep 25
    Reported Nov 6
    		$-0.16$-0.26+38.46%Beat+27.3%
    Jun 25
    Reported Aug 7
    		$-0.23$-0.25+8.00%Beat+8.0%
    Mar 25
    Reported May 8
    		$-0.28$-0.23-21.74%Miss+3.4%
    Dec 24
    Reported Mar 5
    		$-0.23$-0.18-30.68%Miss-4.5%
    Sep 24
    Reported Nov 7
    		$-0.22$-0.21-4.76%Miss+18.5%
    Jun 24
    Reported Aug 1
    		$-0.25$-0.30+16.67%Beat+16.7%
    Mar 24
    Reported May 2
    		$-0.29$-0.28-3.57%Miss+17.1%
    Dec 23
    Reported Mar 7
    		$-0.22$-0.32+31.25%Beat+37.1%
    Sep 23
    Reported Nov 7
    		$-0.27$-0.33+18.18%Beat+41.3%
    Jun 23
    Reported Aug 3
    		$-0.30$-0.34+11.76%Beat+40.0%
    Mar 23
    Reported May 4
    		$-0.35$-0.39+10.26%Beat+28.6%
    Dec 22
    Reported Mar 13
    		$-0.35$-0.42+16.67%Beat-2.9%
    Sep 22
    Reported Nov 10
    		$-0.46$-0.46+0.00%Beat-7.0%
    Jun 22
    Reported Aug 11
    		$-0.50$-0.42-19.05%Miss+72.7%
    Mar 22
    Reported May 10
    		$-0.49$-0.40-22.50%Miss+62.0%
    Dec 21
    Reported Mar 24
    		$-0.34$-0.39+12.82%Beat+86.8%
    Sep 21
    Reported Nov 10
    		$-0.43$-0.37-16.22%Miss+77.9%
    Jun 21
    Reported Jul 15
    		$-1.83$-1.72-6.40%Miss-
    Mar 21
    Reported Jun 2
    		$-1.29$-0.35-268.57%Miss-
    Dec 20
    Reported Mar 31
    		$-2.57$0.00N/AMiss-
    Dec 19
    Reported Mar 31
    		$-1.94$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-16.64EV/EBITDAN/A
    Price/FCF-21.49xFCF Yield-4.65%
    Profitability
    Profit Margin-35.70%Operating Margin-16.60%
    ROE-48.40%ROIC-29.70%
    Financial Health
    Debt/Equity0.77xInterest Coverage-5.41x
    Current Ratio4.95xQuick Ratio4.67x
    Trading Statistics
    Beta2.45Avg Volume312.66K
    52-Week High$9.7152-Week Low$3.38

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$8.98
    SMA 20$8.79
    SMA 50$8.59
    SMA 200$5.99
    EMA 10$9.08
    EMA 20$8.89
    EMA 50$8.39
    EMA 200$6.61

    MACD

    Line: 0.22Signal: 0.16Hist: 0.06

    ADX

    ADX: 17.0+DI: 27.3-DI: 14.9

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down36.0
    PSAR$8.23

    Bollinger Bands

    Upper Band$9.54
    Lower Band$8.04
    %B Position1708%(Upper)
    Band Width0.85

    RSI (14-Day)

    Neutral
    59.3

    Momentum Oscillators

    Stoch %K87.7
    Stoch %D87.2
    Williams %R-20.1
    ROC (10d)12.6%
    Momentum1.04
    CCI (20d)147.2
    MFI (14d)57.1

    Volatility Measures

    ATR (14d)$0.43(4.6%)
    StdDev (20d)0.38
    Hist Vol57.4%(High)

    Volume Flow

    VWAP$9.38
    OBV9.1M
    AD Line111.7K
    CMF (20d)0.101

    Volume Metrics

    Avg Vol (20d)307.0K
    Vol Ratio0.9x
    VWMA (20d)$8.80

    Pivot Points

    R3$10.10
    R2$9.86
    R1$9.72
    Pivot Point$9.48
    S1$9.34
    S2$9.10
    S3$8.96

    Advanced Oscillators

    TSI14.12
    Ultimate Osc56.5
    KST42.13

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$23.39M$19.70M$20.39M$19.91M$19.56M$17.51M$19.07M$20.16M$21.37M$19.27M$18.75M$20.01M
    Cost of Revenue$2.01M$2.72M$2.60M$2.71M$2.98M$2.41M$2.51M$3.25M$3.02M$2.79M$2.77M$2.68M
    Gross Profit$21.37M$16.98M$17.79M$17.20M$16.59M$15.09M$16.56M$16.91M$18.34M$16.47M$15.98M$17.33M
    Operating Expenses$25.26M$29.39M$21.46M$25.10M$28.25M$28.95M$28.49M$28.14M$31.00M$31.20M$27.09M$30.74M
    R&D$2.51M$2.55M$2.44M$3.35M$4.39M$4.43M$4.29M$4.75M$4.32M$4.64M$3.43M$4.24M
    SG&A$22.75M$26.84M$19.02M$21.75M$23.87M$24.52M$24.20M$23.39M$26.68M$26.56M$23.66M$26.50M
    Operating Income$-3,888,000$-12,413,000$-3,668,000$-7,905,000$-11,667,000$-13,859,000$-11,929,000$-11,229,000$-12,651,000$-14,723,000$-11,108,000$-13,411,000
    Interest Income$678,000$741,000$834,000$965,000$1.03M$1.15M$1.29M$1.45M$1.53M$1.65M$1.79M$1.90M
    Interest Expense$1.29M$1.27M$1.29M$1.31M$1.28M$1.26M$1.16M$1.15M$1.15M$3.17M$1.35M$1.43M
    Income Before Tax$-4,418,000$-12,969,000$-4,154,000$-8,248,000$-11,901,000$-14,113,000$-11,808,000$-10,900,000$-12,314,000$-16,249,000$-10,681,000$-12,957,000
    Income Tax Expense$28,000$11,000$8,000$-79,000$40,000$41,000$38,000$166,000$15,000$17,000$10,000$78,000
    Net Income$-4,446,000$-12,980,000$-4,162,000$-8,169,000$-11,941,000$-14,154,000$-11,846,000$-11,066,000$-12,329,000$-16,266,000$-10,691,000$-13,035,000
    EBITDA$-3,469,000$-12,106,000$-3,361,000$-7,553,000$-11,281,000$-13,621,000$-11,556,000$-10,663,000$-12,435,000$-14,445,000$-10,798,000$-13,104,000
    EBIT$-3,806,000$-12,442,000$-3,699,000$-7,907,000$-11,643,000$-13,998,000$-11,935,000$-11,203,000$-12,695,000$-14,731,000$-11,119,000$-13,422,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SGHT

    News

    Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Should You Buy?

    Sight Sciences, Inc. (SGHT) is projected to report a year-over-year increase in earnings and higher revenues for the quarter ended September 2026. Analysts expect a quarterly loss of $0.12 per share and revenues...

    Yahoo! Finance Canada•10/28/26•Bullish

    Sight Sciences, Inc. Estimates – NASDAQ:SGHT

    This page on TradingView provides financial estimates and data for Sight Sciences, Inc. (NASDAQ: SGHT). Users can explore reported financial data and analyst estimates across various financial statements and valuation...

    TradingView•10/25/26•Neutral

    Sight Sciences Q3FY27 Results: Earnings call set for November 4

    Sight Sciences will report its financial results for the third quarter ended September 30, 2026, after market close on Wednesday, November 4...

    scanx.trade•10/22/26•Neutral

    Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

    Sight Sciences, Inc. (Nasdaq: SGHT) announced it will release its financial results for the third quarter ended September 30, 2026, after the market closes on Wednesday, November 4...

    GlobeNewswire•10/21/26•Neutral

    Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

    Sight Sciences, Inc. (Nasdaq: SGHT) announced it will report its financial results for the third quarter ended September 30, 2026, after the market close on Wednesday, November 4...

    Yahoo! Finance Canada•10/21/26•Neutral

    SGHT Valuation and Fair Value

    P/E
    -16.6x
    P/FCF
    -21.5x
    P/B
    9.6x
    See GNG's fair value

    SGHT Profitability: Margins, ROIC and FCF

    Gross margin
    88.0%
    Operating margin
    -16.6%
    Net margin
    -35.7%
    ROIC
    -29.7%
    ROE
    -48.4%
    FCF yield
    -4.7%

    SGHT Competitors

    CompanyTicker
    Valneva SE ADRVALN
    Oncology Institute IncTOI
    ProKidney Corp.PROK
    CytomX Therapeutics IncCTMX
    Tactile Systems Technology IncTCMD
    Oculis Holding AG Ordinary sharesOCS
    ZimVie IncZIMV
    Surrozen IncSRZN

    Sector: Healthcare

    SGHT Analyst Ratings

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    1
    Buy
    4
    Hold
    2
    Sell
    0
    Strong Sell
    0

    SGHT Bull Case vs Bear Case

    Bull case

    • SGHT grew quarterly revenue 19.5% year over year.
    • 71.4% of SGHT's analyst ratings are Buy or Strong Buy.

    Bear case

    • SGHT has a -35.7% net profit margin.

    SGHT Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    8.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.12
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 1 down

    Frequently Asked Questions About SGHT

    Does SGHT pay dividends?

    Sight Sciences Inc (SGHT) does not currently pay a regular dividend.

    What is SGHT's market cap?

    Sight Sciences Inc (SGHT) has a market capitalization of $513.42M with a current stock price of $9.32.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In